Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Missed opportunities to prevent perinatal human immunodeficiency virus transmission in 15 jurisdictions in the United States during 2005-2008.

Whitmore SK, Patel-Larson A, Espinoza L, Ruffo NM, Rao S.

Women Health. 2010 Jul;50(5):414-25. doi: 10.1080/03630242.2010.506153.

PMID:
20853217
2.

Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort.

Peters V, Liu KL, Dominguez K, Frederick T, Melville S, Hsu HW, Ortiz I, Rakusan T, Gill B, Thomas P.

Pediatrics. 2003 May;111(5 Pt 2):1186-91.

PMID:
12728136
3.

U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.

Mofenson LM; Centers for Disease Control and Prevention, U.S. Public Health Service Task Force.

MMWR Recomm Rep. 2002 Nov 22;51(RR-18):1-38; quiz CE1-4.

4.

Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in Thailand.

Jourdain G, Mary JY, Coeur SL, Ngo-Giang-Huong N, Yuthavisuthi P, Limtrakul A, Traisathit P, McIntosh K, Lallemant M; Perinatal HIV Prevention Trial Group, Thailand.

J Infect Dis. 2007 Dec 1;196(11):1629-36. Epub 2007 Oct 25.

5.

Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.

[No authors listed]

MMWR Recomm Rep. 1998 Jan 30;47(RR-2):1-30. Erratum in: MMWR Morb Mortal Wkly Rep 1998 Apr 24;47(15):315. MMWR Morb Mortal Wkly Rep 1998 Apr 17;47(14):287.

6.

Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.

Mofenson LM, Lambert JS, Stiehm ER, Bethel J, Meyer WA 3rd, Whitehouse J, Moye J Jr, Reichelderfer P, Harris DR, Fowler MG, Mathieson BJ, Nemo GJ.

N Engl J Med. 1999 Aug 5;341(6):385-93.

7.

Correlates of mother-to-child transmission of HIV in the United States and Puerto Rico.

Whitmore SK, Taylor AW, Espinoza L, Shouse RL, Lampe MA, Nesheim S.

Pediatrics. 2012 Jan;129(1):e74-81. doi: 10.1542/peds.2010-3691. Epub 2011 Dec 5.

8.

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.

Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, Hayani K, Handelsman E, Smeriglio V, Hoff R, Blattner W; Women and Infants' Transmission Study Group.

J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):484-94.

PMID:
11981365
9.

HIV infection and zidovudine use in childbearing women.

Sia J, Paul S, Martin RM, Cross H.

Pediatrics. 2004 Dec;114(6):e707-12. Epub 2004 Nov 15.

PMID:
15545619
10.

Risk factors of preterm delivery in HIV-infected pregnant women receiving zidovudine for the prevention of perinatal HIV.

Traisathit P, Mary JY, Le Coeur S, Thantanarat S, Jungpichanvanich S, Pornkitprasarn W, Gomutbutra V, Matanasarawut W, Wannapira W, Lallemant M.

J Obstet Gynaecol Res. 2009 Apr;35(2):225-33.

PMID:
19708170
11.

Missed opportunities for congenital syphilis and HIV perinatal transmission prevention.

Rodrigues CS, Guimarães MD, César CC.

Rev Saude Publica. 2008 Oct;42(5):851-8.

13.

Perinatally acquired HIV-1 infection: prevention and evaluation of HIV-exposed infants.

Shetty AK.

Semin Pediatr Infect Dis. 2005 Oct;16(4):282-95. Review.

PMID:
16210108
14.
15.

Reduction in the risk of vertical transmission of HIV-1 associated with treatment of pregnant women with orally administered zidovudine alone.

Simpson BJ, Shapiro ED, Andiman WA.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Feb 1;14(2):145-52.

PMID:
9052723
16.

[Mother-to-child transmission of human immunodeficiency virus (HIV-I): evaluation of control measures in the city of Santos].

Nishimoto TM, Eluf Neto J, Rozman MA.

Rev Assoc Med Bras. 2005 Jan-Feb;51(1):54-60. Epub 2005 Mar 15. Portuguese.

17.

Preventing perinatal HIV transmission: zidovudine use during pregnancy.

Carmichael C.

Am Fam Physician. 1997 Jan;55(1):171-4, 177-8. Review.

PMID:
9012276
18.

Lower mother-to-child HIV-1 transmission in boys is independent of type of delivery and antiretroviral prophylaxis: the Italian Register for HIV Infection in Children.

Galli L, Puliti D, Chiappini E, Gabiano C, Tovo PA, Pezzotti P, de Martino M; Writing Commitee.

J Acquir Immune Defic Syndr. 2005 Dec 1;40(4):479-85.

PMID:
16280705
19.

Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1?

Galli L, Puliti D, Chiappini E, Gabiano C, Ferraris G, Mignone F, Viganò A, Giaquinto C, Genovese O, Anzidei G, Badolato R, Buffolano W, Maccabruni A, Salvini F, Cellini M, Ruggeri M, Manzionna M, Bernardi S, Tovo P, de Martino M; Italian Register for HIV Infection in Children.

Clin Infect Dis. 2009 May 1;48(9):1310-7. doi: 10.1086/597774.

20.

Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.

Coffie PA, Ekouevi DK, Chaix ML, Tonwe-Gold B, Clarisse AB, Becquet R, Viho I, N'dri-Yoman T, Leroy V, Abrams EJ, Rouzioux C, Dabis F.

Clin Infect Dis. 2008 Feb 15;46(4):611-21. doi: 10.1086/526780.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk